Rare diseases
Investigational molecules
Locations
4960 Peachtree Industrial Boulevard Suite 240, 30071-1580, United States
Research activity is centered on esophageal varices in the setting of nonalcoholic steatohepatitis (NASH)–related cirrhosis, with attention to complications linked to advanced liver disease and increased portal pressure.
The sponsor’s clinical research is focused on preventing variceal development in patients with cirrhosis associated with metabolic liver injury.
Galectin Therapeutics Inc. runs clinical trials in conditions such as Varices oesophageal, Hepatic cirrhosis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
